We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 25 start-ups with an aggregate funding of $1.6b. The average funding per company in this subset is $63.7m.
Last update to the database: Feb 18, 2025. See changelog.
4
Funding Rounds
$14.1m
Money raised
Qnami is a quantum technology company that is developing and commercializing quantum sensing and quantum imaging technologies using synthetic diamond and quantum technologies. Qnami's products are in life-science R&D and semiconductor electronics.
2
Funding Rounds
$22.7m
Money raised
FoRx Therapeutics is a Basel-based biotechnology company developing a drug discovery platform for cancer drugs.
7
Funding Rounds
$84.5m
Money raised
Promedior is a company founded in 1896 by Jim Broderick.
3
Funding Rounds
$88.9m
Money raised
Invaio is a Cambridge, Massachusetts-based biotechnology company founded by Ignacio Martinez.
3
Funding Rounds
$317.0m
Money raised
Treatment developer for central nervous system (CNS) disorders patient.
2
Funding Rounds
$48.0m
Money raised
Skyhawk Therapeutics is a RNA-correcting Small Molecules founded in 2016 by Bill Haney.
2
Funding Rounds
$31.8m
Money raised
Engimmune Therapeutics is a platform engineering next-generation T cell receptor therapies founded in 2021 by Søren Mouritsen.
2
Funding Rounds
$41.1m
Money raised
BioVersys AG is a drug Discovery founded in 2008.
2
Funding Rounds
$42.0m
Money raised
NBE Therapeutics is a Basel-based biotechnology company specializing in oncology. The company has developed an antibody drug conjugate platform targeting solid tumors.
3
Funding Rounds
$400.0m
Money raised
Cell and Immunotherapy (SCIP) platform.
4
Funding Rounds
$120.5m
Money raised
NousCom is a viral vector-based cancer vaccines developer founded in 2015.
4
Funding Rounds
$24.1m
Money raised
Versameb is a Basel-based biotechnology company focusing on discovering and developing RNA-based drugs for modulation of protein expression.
3
Funding Rounds
$155.0m
Money raised
Anaveon is a company founded in 2017.
1
Funding Rounds
$9.9k
Money raised
Certus Molecular Diagnostics is a Basel-based medical diagnostics company developing molecular rapid tests for the detection of pathogens and custom diagnostic manufacturing for individual healthcare provider needs.
2
Funding Rounds
$60.0m
Money raised
Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies.
2
Funding Rounds
$12.7m
Money raised
Resistell is an antibiotic resistance test founded in 2018.
1
Funding Rounds
$2.0m
Money raised
GenAI clinical decision support platform for cancer genomics insights.
2
Funding Rounds
$100.0m
Money raised
Developer of novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
1
Funding Rounds
$177.0k
Money raised
Developer of novel therapeutics for autism spectrum disorders.
1
Funding Rounds
$14.0m
Money raised
Scailyte is a true precision medicine through single-cell science.
1
Funding Rounds
$3.9m
Money raised
Immunosuppressive drugs manufacturer for autoimmune diseases and transplantations.
1
Funding Rounds
$150.0k
Money raised
Biotechnology company developing treatments to enhance immune system responses.
1
Funding Rounds
$3.5m
Money raised
Allegria Therapeutics is a therapeutics developer for mast cell-mediated diseases founded in 2023.
1
Funding Rounds
$1.4m
Money raised
Ymmunobio is a preclinical-stage oncology platform founded in 2021.
1
Funding Rounds
$4.3m
Money raised
AERA Health is a preventive health technology founded in 2022.
Enter your email and get access to 71,000 + technology companies you can partner with.